Stay updated on CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Sign up to get notified when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.

Latest updates to the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (CA, CT, FL, MA, MN, OH, TX, WA) and updated revision to v3.3.3; removed the separate state-location subsections and the HHS Vulnerability Disclosure link (v3.3.2).SummaryDifference1.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page footer shows a revision update from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoved the government funding lapse notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedNo significant changes detected in the page content or structure; the study information remains consistent with the prior version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange Detected- Added a new page revision tag: v3.2.0. - Removed the specific resource entry: Genetic and Rare Diseases Information Center resources: Ovarian cancer. - Also indicates a prior revision tag: v3.0.2.SummaryDifference0.4%

Stay in the know with updates to CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.